Artia-Global-Partners-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
32
Total Value
246552243
Accession Number
0001937964-25-000004
Form Type
13F-HR
Manager Name
Artia-Global-Partners-Lp
Data Enrichment
97% identified
31 identified1 unidentified

Holdings

32 positions • $246.6M total value
Manager:
Search and click to pin securities to the top
Page 2 of 2
TG THERAPEUTICS, INC.
Shares:54.5K
Value:$2.1M
% of Portfolio:0.9% ($2.1M/$246.6M)
INTUITIVE SURGICAL INC
Shares:3.5K
Value:$1.7M
% of Portfolio:0.7% ($1.7M/$246.6M)
EyePoint Pharmaceuticals, Inc.
Shares:316.7K
Value:$1.7M
% of Portfolio:0.7% ($1.7M/$246.6M)
NEUROCRINE BIOSCIENCES INC
Shares:14.7K
Value:$1.6M
% of Portfolio:0.7% ($1.6M/$246.6M)
UNITED THERAPEUTICS Corp
Shares:5.0K
Value:$1.5M
% of Portfolio:0.6% ($1.5M/$246.6M)
Xenon Pharmaceuticals Inc.
Shares:40.0K
Value:$1.3M
% of Portfolio:0.5% ($1.3M/$246.6M)
Ascendis Pharma A/S
Shares:7.4K
Value:$1.2M
% of Portfolio:0.5% ($1.2M/$246.6M)
Janux Therapeutics, Inc.
Shares:38.1K
Value:$1.0M
% of Portfolio:0.4% ($1.0M/$246.6M)
Mereo BioPharma Group plc
Shares:421.4K
Value:$948.1K
% of Portfolio:0.4% ($948.1K/$246.6M)
Travere Therapeutics, Inc.
Shares:30.9K
Value:$553.7K
% of Portfolio:0.2% ($553.7K/$246.6M)
Centessa Pharmaceuticals plc
Shares:35.2K
Value:$506.6K
% of Portfolio:0.2% ($506.6K/$246.6M)
Oruka Therapeutics, Inc.
Shares:7.4K
Value:$75.7K
% of Portfolio:0.0% ($75.7K/$246.6M)